Emerging cardiovascular indications of mineralocorticoid receptor antagonists.
about
Efficacy and safety of mineralocorticoid receptor antagonists for patients with heart failure and diabetes mellitus: a systematic review and meta-analysisEplerenone restores 24-h blood pressure circadian rhythm and reduces advanced glycation end-products in rhesus macaques with spontaneous hypertensive metabolic syndromeNew agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?Therapeutic Targeting of Cellular Stress to Prevent Cardiovascular Disease: A Review of the Evidence.Perivascular adipose tissue as a regulator of vascular disease pathogenesis: identifying novel therapeutic targets.Spironolactone in cardiovascular disease: an expanding universe?
P2860
Emerging cardiovascular indications of mineralocorticoid receptor antagonists.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Emerging cardiovascular indications of mineralocorticoid receptor antagonists.
@en
type
label
Emerging cardiovascular indications of mineralocorticoid receptor antagonists.
@en
prefLabel
Emerging cardiovascular indications of mineralocorticoid receptor antagonists.
@en
P2093
P50
P1476
Emerging cardiovascular indications of mineralocorticoid receptor antagonists.
@en
P2093
Abdallah Al-Mohammad
David Adlam
Yasir Parviz
P304
P356
10.1016/J.TEM.2015.01.007
P577
2015-02-20T00:00:00Z